Study Overview
Sex: All
Age: 18 Years / N/A
No Study Documents
Locations
Study Overview
Sex: All
Age: 18 Years / N/A
No Study Documents
Recruiting
Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer
Beigene Study ID
ClinicalTrials.gov ID
Sex: All
Age: 18 Years / N/A
No Study Documents
Sex: All
Age: 18 Years / N/A
No Study Documents